(Q72614735)
Statements
Pharmacokinetics, pharmacodynamics, and tolerability of cabergoline, a prolactin-lowering drug, after administration of increasing oral doses (0.5, 1.0, and 1.5 milligrams) in healthy male volunteers (English)
A C Andreotti
E Pianezzola
S Persiani
M A Pacciarini
M Strolin Benedetti